Nervonik is a Biotech company based in California. It has raised $17M in total funding. Latest round: Series A.
Nervonik is a Biotech company based in California. Nervonik has raised $17M in total disclosed funding. That places its disclosed total in the $1M–$25M range. Its most recent disclosed round is a Series A announced in March 2025. The round record for Nervonik runs through 2025; nothing later has been disclosed. Investors on record include U.S. Venture Partners, Foothill Ventures, Correlation Ventures, Shangbay Capital, Camford Capital, Joyance Partners and 2 others. 8 distinct backers are named across the disclosed rounds.
Round data for Nervonik is compiled from public filings and announcements; blank fields mean nothing has been disclosed rather than nothing exists. Continue with the Biotech companies in California and backer lists below.
Company funding database · Investor directory · Founder database · Mega-rounds 2026